Clinical Trial Update: An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for an investigational obesity drug in overweight patients; the study 0364-006 sponsored by Merck Sharp & Dohme LLC has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity | Phase 2 | Status: COMPLETED